We are live on ! Find out more
PC

Pavadi Capital Portfolio holdings

AUM $81.2M
1-Year Est. Return 5.26%
This Fund
S&P 500
This Quarter Est. Return
-1.27%
1 Year Est. Return
+5.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$104M
AUM Growth
-$5.87M
Cap. Flow
-$1.87M
Cap. Flow %
-1.79%
Top 10 Hldgs %
55.87%
Holding
25
New
3
Increased
1
Reduced
19
Closed
2

Top Buys

Rank Stock Value
1
UHS icon
Universal Health Services
UHS
+$5.02M
2
COR icon
Cencora
COR
+$4.53M
3
MD icon
Pediatrix Medical
MD
+$3.37M
4
HCA icon
HCA Healthcare
HCA
+$959K

Top Sells

Rank Stock Value
1
NVST icon
Envista
NVST
+$3.41M
2
PHG icon
Philips
PHG
+$3.1M
3
CNC icon
Centene
CNC
+$834K
4
MOH icon
Molina Healthcare
MOH
+$833K
5
CAH icon
Cardinal Health
CAH
+$748K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MOH icon
1
Molina Healthcare
MOH
$10.2B
$8.84M 8.46%
26,787
-2,587
-9% -$833K
CAH icon
2
Cardinal Health
CAH
$53.9B
$8.16M 7.82%
122,423
-11,804
-9% -$748K
CNC icon
3
Centene
CNC
$30.7B
$7.53M 7.21%
96,775
-9,333
-9% -$834K
AMN icon
4
AMN Healthcare
AMN
$1.3B
$5.96M 5.71%
56,268
-5,432
-9% -$595K
DGX icon
5
Quest Diagnostics
DGX
$25.7B
$5.16M 4.94%
42,090
-4,066
-9% -$535K
HUM icon
6
Humana
HUM
$43.7B
$4.83M 4.63%
9,961
-963
-9% -$468K
HOLX
7
DELISTED
Hologic
HOLX
$4.56M 4.36%
70,630
-6,808
-9% -$472K
CVS icon
8
CVS Health
CVS
$133B
$4.53M 4.34%
47,541
-4,592
-9% -$455K
THC icon
9
Tenet Healthcare
THC
$20.5B
$4.46M 4.27%
86,536
-8,345
-9% -$495K
CI icon
10
Cigna
CI
$73.8B
$4.3M 4.12%
15,510
-1,499
-9% -$422K
UNH icon
11
UnitedHealth
UNH
$376B
$4.3M 4.12%
8,514
-821
-9% -$432K
UHS icon
12
Universal Health Services
UHS
$10.2B
$4.28M 4.1%
+48,556
New +$5.02M
COR icon
13
Cencora
COR
$60.6B
$4.27M 4.09%
+31,537
New +$4.53M
HCA icon
14
HCA Healthcare
HCA
$87.2B
$4.19M 4.01%
22,795
+4,815
+27% +$959K
LH icon
15
Labcorp
LH
$25.4B
$3.98M 3.82%
22,647
-2,185
-9% -$447K
ELV icon
16
Elevance Health
ELV
$81.5B
$3.79M 3.63%
8,346
-803
-9% -$384K
INMD icon
17
InMode
INMD
$870M
$3.77M 3.61%
129,357
-12,477
-9% -$387K
MRVI icon
18
Maravai LifeSciences
MRVI
$969M
$3.69M 3.53%
144,569
-13,951
-9% -$350K
SYNH
19
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$3.32M 3.18%
70,365
-6,790
-9% -$439K
FLGT icon
20
Fulgent Genetics
FLGT
$470M
$2.83M 2.71%
74,125
-7,152
-9% -$359K
MD icon
21
Pediatrix Medical
MD
$2.18B
$2.76M 2.64%
+167,304
New +$3.37M
XRAY icon
22
Dentsply Sirona
XRAY
$2.68B
$2.67M 2.56%
94,340
-9,094
-9% -$311K
QDEL icon
23
QuidelOrtho
QDEL
$1.14B
$2.24M 2.14%
31,327
-3,026
-9% -$271K
NVST icon
24
Envista
NVST
$4.44B
– –
-88,456
Closed -$3.41M
PHG icon
25
Philips
PHG
$25.7B
– –
-167,870
Closed -$3.1M

Similar funds

BAM
Broadmark Asset Management San Francisco, California $80.4M AUM 29.98% 1-Year Est. Return
TCM
Tegean Capital Management New York $82.1M AUM 12.91% 1-Year Est. Return
JAM
JLP Asset Management New York $84.2M AUM 10.86% 1-Year Est. Return
HH
HP Holding New York $84.5M AUM 4.73% 1-Year Est. Return
CPI
Canaan Partners IX Menlo Park, California $87.5M AUM
SLM
Snow Lake Management Menlo Park, California $90.7M AUM 72.65% 1-Year Est. Return
AFG
Alterity Financial Group Bangor, Maine $69.9M AUM 40.65% 1-Year Est. Return
TIMH
Tilt Investment Management Holdings New York $92.6M AUM 28.92% 1-Year Est. Return

Pavadi Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Pavadi Capital held 25 positions worth $104M, down 5.3% from $110M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Pavadi Capital's Q3 2022 filing shows 3 new, 1 increased, 19 reduced and 2 closed positions. Its largest new stake was Universal Health Services: 48,556 shares worth $4.28M. The largest sale was Envista, an estimated $3.41M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Pavadi Capital's largest Q3 2022 buy was Universal Health Services: 48,556 shares worth $4.28M.
  • Pavadi Capital added most to HCA Healthcare in Q3 2022, an estimated $959K increase.
  • Pavadi Capital's biggest Q3 2022 reduction was Centene, cutting an estimated $834K.
  • Pavadi Capital fully exited Envista in Q3 2022, selling an estimated $3.41M.
  • Pavadi Capital's ten largest holdings make up 56% of its $104M portfolio in Q3 2022.
  • Pavadi Capital opened 3 new positions and closed 2 in Q3 2022.
  • Pavadi Capital's portfolio value fell 5.3% quarter-over-quarter to $104M.

Based on Pavadi Capital's 13F filing for Q3 2022, filed 14 Nov 2022.